Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007
暂无分享,去创建一个
A. Hidrón | J. Edwards | J. Patel | T. Horan | D. Sievert | D. Pollock | S. Fridkin | A. Hidrón
[1] J. Vincent,et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. , 1995, JAMA.
[2] National Nosocomial Infections Surveillance (NNIS) System report, data summary from October 1986-April 1998, issued June 1998. , 1998, American journal of infection control.
[3] M. Pfaller,et al. Survey of bloodstream infections due to gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[4] Nnis System,et al. National Nosocomial Infections Surveillance (NNIS) System Report, Data Summary from January 1990-May 1999, issued June 1999. A report from the NNIS System. , 1999, American journal of infection control.
[5] R. Gaynes,et al. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[6] M. Pfaller,et al. Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections in the USA, Canada and Latin America. SENTRY Participants Group. , 2000, International journal of antimicrobial agents.
[7] J Edwards,et al. Characteristics of hospitals and infection control professionals participating in the National Nosocomial Infections Surveillance System 1999. , 2001, American journal of infection control.
[8] J. Verhoef,et al. Frequency of Isolation and Antimicrobial Resistance of Gram-Negative and Gram-Positive Bacteria from Patients in Intensive Care Units of 25 European University Hospitals Participating in the European Arm of the SENTRY Antimicrobial Surveillance Program 1997–1998 , 2001, European Journal of Clinical Microbiology and Infectious Diseases.
[9] J. Verhoef,et al. Frequency of Isolation of Pathogens from Bloodstream, Nosocomial Pneumonia, Skin and Soft Tissue, and Urinary Tract Infections Occurring in European Patients , 2001, European Journal of Clinical Microbiology and Infectious Diseases.
[10] R. Gaynes,et al. Temporal Changes in Prevalence of Antimicrobial Resistance in 23 U.S. Hospitals , 2002, Emerging infectious diseases.
[11] Nnis System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003. , 2003, American journal of infection control.
[12] R. Wenzel,et al. Annals of Clinical Microbiology and Antimicrobials Open Access Emerging Resistance among Bacterial Pathogens in the Intensive Care Unit – a European and North American Surveillance Study (2000–2002) Intensive-care Unitantibiotic Susceptibility , 2022 .
[13] P. Bradford,et al. Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York City. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[14] National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. , 2004, American journal of infection control.
[15] Ronald N. Jones,et al. Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001). , 2004, International journal of antimicrobial agents.
[16] H. Chambers,et al. Community-associated MRSA--resistance and virulence converge. , 2005, The New England journal of medicine.
[17] Clinical,et al. Analysis and presentation of cumulative antimicrobial susceptibility test data; approved guideline , 2005 .
[18] Richard Platt,et al. Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillin-resistant Staphylococcus aureus bacteremia. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[19] Wonkeun Song,et al. Prevalence of Newer β-Lactamases in Gram-Negative Clinical Isolates Collected in the United States from 2001 to 2002 , 2006, Journal of Clinical Microbiology.
[20] R. Gaynes,et al. Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[21] S. Leone,et al. Antimicrobial treatment for Intensive Care Unit (ICU) infections including the role of the infectious disease specialist. , 2007, International journal of antimicrobial agents.
[22] J. Bartlett,et al. Anti-infective research and development--problems, challenges, and solutions. , 2007, The Lancet. Infectious diseases.
[23] B. Wickes,et al. First Report of the Emergence of CTX-M-Type Extended-Spectrum β-Lactamases (ESBLs) as the Predominant ESBL Isolated in a U.S. Health Care System , 2007, Antimicrobial Agents and Chemotherapy.
[24] J. Edwards,et al. National Healthcare Safety Network (NHSN) Report, data summary for 2006, issued June 2007. , 2007, American journal of infection control.
[25] J. Quinn,et al. Antimicrobial Resistance among Gram-Negative Bacilli Causing Infections in Intensive Care Unit Patients in the United States between 1993 and 2004 , 2007, Journal of Clinical Microbiology.
[26] Y. Carmeli,et al. Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. , 2007, The Journal of antimicrobial chemotherapy.
[27] Ronald N. Jones,et al. Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance program. , 2007, Diagnostic microbiology and infectious disease.
[28] J. Blanco,et al. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. , 2007, The Journal of antimicrobial chemotherapy.
[29] Kelly D Peterson,et al. National Healthcare Safety Network (NHSN) report: data summary for 2006 through 2008, issued December 2009. , 2008, American journal of infection control.